Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - sildenafil - film-coated tablet - 50 milligram(s) - drugs used in erectile dysfunction; sildenafil

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - sildenafil - film-coated tablet - 100 milligram(s) - drugs used in erectile dysfunction; sildenafil

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sildenafil citrate, quantity: 35.1 mg (equivalent: sildenafil, qty 25 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; magnesium stearate; copovidone; microcrystalline cellulose; saccharin sodium; calcium hydrogen phosphate; croscarmellose sodium - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sildenafil citrate, quantity: 140.4 mg (equivalent: sildenafil, qty 100 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; copovidone; croscarmellose sodium; saccharin sodium; indigo carmine aluminium lake; calcium hydrogen phosphate; magnesium stearate - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sildenafil citrate, quantity: 70.2 mg (equivalent: sildenafil, qty 50 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; croscarmellose sodium; microcrystalline cellulose; calcium hydrogen phosphate; magnesium stearate; copovidone; saccharin sodium - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

Israel - English - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 100 mg - sildenafil - sildenafil teva ® 100 mg fc tablets is indicated for the treatment of erectile dysfunction.

Israel - English - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 25 mg - sildenafil - sildenafil teva ® 25 mg fc tablets is indicated for the treatment of erectile dysfunction.

Israel - English - Ministry of Health

abic marketing ltd, israel - sildenafil as citrate - film coated tablets - sildenafil as citrate 50 mg - sildenafil - sildenafil teva® 50 mg fc tablets is indicated for the treatment of erectile dysfunction.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy [see clinical studies (14) ]. studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use : adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)]. sildenafil tablets are contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)] . - concomitant use of riociguat, a guanylate cyclase stimulator. p

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; croscarmellose sodium; calcium hydrogen phosphate; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.